(Q57877211)

4

Antonella d'Arminio Monforte

0 references

Amanda Mocroft

11

Alicja Wiercińska-Drapało

Amanda Mocroft

0 references

5

Alicja Wiercinska-Drapalo

0 references

Jens Lundgren

10

Jens D. Lundgren

0 references

Ole Kirk

9

Ole Kirk

0 references

Joanne Reekie

1

Joanne Reekie

0 references

author name string

Csaba Kosa

2

0 references

Frederik Engsig

3

0 references

Pere Domingo

6

0 references

Nathan Clumeck

Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals

8

0 references

language of work or name

English

0 references

publication date

26 July 2010

0 references

published in

Cancer

0 references

volume

116

0 references

issue

22

0 references

page(s)

5306-5315

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Trends in cancer risk among people with AIDS in the United States 1980-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Spectrum of AIDS-associated malignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Cancer risk in people infected with human immunodeficiency virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Epstein-Barr virus associated lymphoproliferations in the AIDS setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Association of Cancer With AIDS-Related Immunosuppression in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Human papillomavirus infection and disease in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Risk of cancers during interrupted antiretroviral therapy in the SMART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

7 January 2021

AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part II. Cervical and anal squamous epithelial lesions, lung cancer, testicular germ cell cancers, and skin cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

7 January 2021

The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

7 January 2021

Immune deficiency and risk for malignancy among persons with AIDS

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

7 January 2021

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

7 January 2021

AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part I: Kaposi's sarcoma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

7 January 2021

Marital Status in Relation to Kaposi's Sarcoma, Non-Hodgkin's Lymphoma, and Anal Cancer in the Pre-AIDS Era

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25311

7 January 2021